Zavzpret

This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign In

Log Out

Products

Order

Materials

Request Samples

Hospital Products

Vaccines

Patient Assistance

Pfizer Oncology Together

Pfizer RxPathways

Explore Content

Contact

Menu

Close

About

About

Efficacy

MOA

Mist Moments

Safety & Dosing

Safety &
Dosing

Safety

Dosing

Prescribing

Prescribing

Access & Savings

Zavzpret OneSource

Practice Resources

Practice Resources

Events

Materials

Videos

PA Resources

Prescribing Information

Patient Information

Instructions for Use

Indication

Search

Please note: Search results may not reflect the intention of the user and conclusions should not be drawn from the presence or absence of a result.

Search Tips:

Try using synonyms as what you’re looking for might use slightly different words.

Try more general terms in place of specific ones.

Search Tips:

Try using synonyms as what you’re looking for might use slightly different words.

Try more general terms in place of specific ones.

Search Tips:

Try using synonyms as what you’re looking for might use slightly different words.

Try more general terms in place of specific ones.

In order to access results for other products, please visit our Products page.

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{description}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{description}}}

{{{productCardLinks}}}

{{{productCardBrandUrl}}}

We are unable to show you product specific search results on PfizerPro.com

{{{loggedOutMessageHelper}}}

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{description}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{description}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{description}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

{{#unless titleLink}} {{/unless}}

{{{preHeader}}}

{{{badgeText}}}

{{{preTitle}}} {{{titleFormatted}}}

{{{preDescription}}} {{{description}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

{{#unless titleLink}} {{/unless}}

{{{titleFormatted}}}

{{{eventDates}}} {{{speakersList 'Speaker(s): '}}} {{{descriptionLinks}}}

{{#unless titleLink}} {{/unless}}

Prescribing information

Results that match your query can be found in the Prescribing information.

IMPORTANT SAFETY INFORMATION

Results that match your query can be found in the Important Safety Information.

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2024 Pfizer Inc. All rights reserved.

PP-ZAZ-USA-0093

You are now leaving Pfizer

You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.
PP-MCL-USA-0367

INDICATION

ZAVZPRET^TM (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Important Safety Information

Contraindications: Hypersensitivity to ZAVZPRET or any of its components.

Warnings and Precautions: Hypersensitivity reactions, including facial swelling and urticaria, have occurred with ZAVZPRET. If a hypersensitivity reaction occurs, discontinue ZAVZPRET and initiate appropriate therapy.

Adverse Reactions: Most common adverse reactions (occurring in ≥2% of patients treated with ZAVZPRET and greater than placebo) for ZAVZPRET vs placebo were taste disorders including dysgeusia and ageusia (18% vs 4%), nausea (4% vs 1%), nasal discomfort (3% vs 1%), and vomiting (2% vs 1%).

Drug Interactions: Avoid use with drugs that inhibit or induce OATP1B3 or NTCP transporters. Avoid use of intranasal decongestants; if unavoidable, administer intranasal decongestants at least 1 hour after ZAVZPRET administration.

Use in Specific Populations: Hepatic Impairment: Avoid use in patients with severe hepatic impairment. Renal impairment: Avoid use of ZAVZPRET in patients with creatinine clearance (CLcr) less than 30 mL/min.

Please click here for full Prescribing Information.

Indication

ZAVZPRET™️ (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Please see Full Prescribing Information.